World Health Organization site
Skip Navigation Links

Main
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 17 October 2012
Main ID:  NCT00960466
Date of registration: 14/08/2009
Primary sponsor: University Hospitals Bristol NHS Trust
Public title: Distress Thermometer Intervention Trial DiTIT
Scientific title: Evaluating the Effect of Monitoring Cancer Patients Using the Distress Thermometer on Levels of Distress and Health Service Costs - a Randomised Controlled Trial
Date of first enrolment: October 2009
Target sample size: 220
Recruitment status: Completed
URL:  http://clinicaltrials.gov/show/NCT00960466
Study type:  Interventional
Study design:  Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Supportive Care  
Countries of recruitment
United Kingdom
Contacts
Name:   William Hollingworth, PhD
Address: 
Telephone:
Email:
Affiliation:  University of Bristol
Key inclusion & exclusion criteria

Inclusion Criteria:

- Primary solid tumour diagnosis within the last 12 months

- Scheduled for outpatient external RT fractions over a period of at least 2 weeks or
scheduled outpatient CT regimen over 2 or more cycles

- Patient aged >= 18 and <85 years

- Ability to read and communicate in English (personally or via translator)

Exclusion Criteria:

- Receiving neoadjuvant CT

- Patient declines consent

- Clinical presentation dictates treatment by a specific therapist not trained in use
of the Distress Thermometer



Age minimum: 18 Years
Age maximum: 85 Years
Gender: Both
Health Condition(s) or Problem(s) studied
Cancer
Intervention(s)
Behavioral: Distress Thermometer and Problems List
Behavioral: Usual psychosocial support
Primary Outcome(s)
Profile of Mood States (POMS) [Time Frame: 1, 6, 12 months post randomisation]
Secondary Outcome(s)
EQ-5D [Time Frame: 1,6,12 months post randomisation]
European Organisation for Research and Treatment of Cancer (EORTC - QLQ 30) cancer-related quality of life measure [Time Frame: 1,6, 12 months post randomisation]
Mortality [Time Frame: 12 months post randomisation]
Resource Use [Time Frame: 12 months post randomisation]
Trent Patient Satisfaction Questionnaire [Time Frame: 1, 6 months post randomisation]
Secondary ID(s)
NIHR # PB-PG-0807-13387
ON/2007/2744
REC # 08/H0101/224
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Royal United Hospital Bath NHS Trust
University of Bristol
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.1 - Version history